|
1 Hematopoiesis and Hematology Testing |
|
|
1 | (9) |
|
Hematopoiesis and Blood Cells |
|
|
1 | (5) |
|
|
|
6 | (4) |
|
2 Disorders of Red Blood Cells |
|
|
10 | (38) |
|
|
|
23 | (1) |
|
Hypochromic/Microcytic Anemia |
|
|
24 | (5) |
|
|
|
29 | (1) |
|
Aplastic Anemia and Hypoplastic Anemia |
|
|
30 | (2) |
|
Pure Red Blood Cell Aplasia |
|
|
32 | (1) |
|
Anemia Related to Hemolysis |
|
|
33 | (4) |
|
Anemia Associated with Hemoglobinopathies |
|
|
37 | (8) |
|
Other Anemia-related Syndromes |
|
|
45 | (3) |
|
3 Disorders of Platelets and Coagulation Factors |
|
|
48 | (18) |
|
|
|
48 | (1) |
|
|
|
49 | (3) |
|
The Natural Inhibitors of Coagulation |
|
|
52 | (1) |
|
|
|
52 | (1) |
|
Inherited Coagulation Disorders |
|
|
53 | (2) |
|
Acquired Coagulation Disorders |
|
|
55 | (3) |
|
Platelets and von Willebrand Factor |
|
|
58 | (4) |
|
Hereditary Thrombotic Disorders and Anticoagulant Therapy Monitoring |
|
|
62 | (4) |
|
4 Disorders of Non-neoplastic White Blood Cells |
|
|
66 | (14) |
|
|
|
66 | (14) |
|
5 Normal Lymph Node, Thymus and Lymphoid Hyperplasia |
|
|
80 | (17) |
|
Normal Lymph Node: Function and Structure |
|
|
80 | (1) |
|
Normal Thymus: Function and Structure |
|
|
81 | (1) |
|
Predominant Patterns and Etiology of Reactive Lymph Node Hyperplasia |
|
|
81 | (2) |
|
|
|
83 | (14) |
|
|
|
97 | (8) |
|
Normal Spleen: Function and Structure |
|
|
97 | (1) |
|
|
|
98 | (7) |
|
7 Myelodysplastic Syndromes |
|
|
105 | (25) |
|
Myelodysplastic Syndromes |
|
|
105 | (3) |
|
Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) |
|
|
108 | (4) |
|
Myeloproliferative Neoplasms |
|
|
112 | (18) |
|
|
|
130 | (21) |
|
WHO Classification and Prognosis |
|
|
130 | (2) |
|
AML with Recurrent Genetic Abnormalities |
|
|
132 | (5) |
|
AML with Myelodysplasia-related Changes |
|
|
137 | (2) |
|
Therapy-related Myeloid Neoplasms (t-AML, t-MDS, t-MDS/MPN) |
|
|
139 | (1) |
|
AML Not Otherwise Categorized |
|
|
139 | (8) |
|
Acute Leukemias of Ambiguous Lineage |
|
|
147 | (4) |
|
9 Acute Lymphoblastic Leukemia/Lymphoma, Mature T- and B-cell Leukemias |
|
|
151 | (24) |
|
Acute Lymphoblastic Leukemia/Lymphoma |
|
|
151 | (8) |
|
|
|
159 | (7) |
|
Mature T-cell Leukemia and Natural Killer Cell-Large Granular Lymphocyte Leukemia (NK-LGLL) |
|
|
166 | (9) |
|
10 Non-Hodgkin Lymphomas, Plasma Cell Neoplasms and Histiocytic/Dendritic Cell Neoplasm |
|
|
175 | (72) |
|
|
|
175 | (53) |
|
|
|
228 | (11) |
|
Histiocytic and Dendritic Cell Neoplasms |
|
|
239 | (8) |
|
|
|
247 | (14) |
|
Classification of Hodgkin's Lymphoma (WHO 2008) |
|
|
248 | (1) |
|
Nodular Lymphocyte Predominant Hodgkin's Lymphoma |
|
|
248 | (13) |
|
12 Lymphoproliferative Disorders Associated with Immunodeficiencies and Post-transplantations |
|
|
261 | (4) |
|
Primary Immune Disorders Associated with Lymphoproliferative Disorders |
|
|
261 | (1) |
|
Disorders Associated with Acquired Immunodeficiency |
|
|
262 | (3) |
|
|
|
265 | (42) |
|
Principles of Flow Cytometry and its Applications |
|
|
265 | (2) |
|
Hematopoietic Cells Maturation |
|
|
267 | (40) |
|
|
|
307 | (18) |
|
Basic Concepts and Terminology |
|
|
307 | (7) |
|
Methods in Molecular Pathology |
|
|
314 | (2) |
|
Genetic Abnormalities and Molecular Basis of Diseases |
|
|
316 | (9) |
|
|
|
325 | (56) |
|
|
|
325 | (36) |
|
|
|
361 | (20) |
|
|
|
381 | (6) |
|
WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues (2016 Updated) |
|
|
381 | (1) |
|
Myeloproliferative Neoplasms |
|
|
381 | (1) |
|
Myeloid and Lymphoid Neoplasms with Eosinophilia and Abnormalities of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2 |
|
|
381 | (1) |
|
Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) |
|
|
381 | (1) |
|
Myelodysplastic Syndromes (MDS) |
|
|
382 | (1) |
|
Acute Myeloid Leukemia (AML) and Related Neoplasms |
|
|
382 | (1) |
|
Blastic Plasmacytoid Dendritic Cell Neoplasm |
|
|
383 | (2) |
|
|
|
385 | (1) |
|
Histiocytic and Dendritic Cell Neoplasms |
|
|
385 | (2) |
| Index |
|
387 | |
